Doctor of Podiatric Medicine Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Christine Stern

Podiatrist, Foot Surgery Coram, NY Doctor of Podiatric Medicine

NPI 1821149329 CMS profile 264686

100 Middle Country Rd, Coram, NY 11727

Open in the dashboard

General payments

$860

30 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Christine Stern of Coram, NY is reported in the CMS Open Payments database as having received $860 across 30 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 54th percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $61 3
2023 General $111 5
2022 General $282 8
2021 General $347 11
2019 General $60 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christine Stern
  • Podiatrist, Foot Surgery median
  • Middle half of Podiatrist, Foot Surgery
  • National median

In program year 2025, general payments to Christine Stern were reported at $0. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.

Show as a table
Year Christine Stern Podiatrist, Foot Surgery median Middle half National median
2019 $60 $167 $67–$484 $163
2020 $0 $114 $40–$323 $114
2021 $347 $171 $57–$502 $132
2022 $282 $196 $66–$556 $149
2023 $111 $187 $78–$466 $160
2024 $61 $190 $78–$557 $164
2025 $0 $180 $70–$569 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Paratek Pharmaceuticals, Inc. $545 16 payments
  2. Smith+Nephew, Inc. $54 3 payments
  3. Kerecis Limited $49 1 payment
  4. Organogenesis Inc. $30 1 payment
  5. Sandoz Inc. $23 1 payment
  6. Boston Scientific Corporation $22 1 payment
  7. Mayne Pharma Inc. $21 1 payment
  8. Novum Pharma, LLC $21 1 payment
  9. Orthofix Medical, Inc. $21 1 payment
  10. Advanced Oxygen Therapy Inc. $20 1 payment
  11. Other $54 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $860 30 payments
Products named General payments · program years 2019–2024
  1. NUZYRA $545 16 payments
  2. Kerecis Omega3 Wound $49 1 payment
  3. Kerecis Omega3 Surgibind $49 1 payment
  4. Kerecis Omega3 GraftGuide $49 1 payment
  5. Kerecis Omega3 SurgiClose $49 1 payment
  6. Physio-Stim $41 2 payments
  7. Puraply $30 1 payment
  8. KERYDIN $23 1 payment
  9. Alcortin A $21 1 payment
  10. Topical wound oxygen $20 1 payment
  11. Other $127 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

30 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record